OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Urinary microbiota and bladder cancer: A systematic review and a focus on uropathogens
Abdourahamane Yacouba, Maryam Tidjani Alou, Jean‐Christophe Lagier, et al.
Seminars in Cancer Biology (2022) Vol. 86, pp. 875-884
Open Access | Times Cited: 31
Abdourahamane Yacouba, Maryam Tidjani Alou, Jean‐Christophe Lagier, et al.
Seminars in Cancer Biology (2022) Vol. 86, pp. 875-884
Open Access | Times Cited: 31
Showing 1-25 of 31 citing articles:
Gut OncoMicrobiome Signatures (GOMS) as next-generation biomarkers for cancer immunotherapy
Andrew Maltez Thomas, Marine Fidelle, Bertrand Routy, et al.
Nature Reviews Clinical Oncology (2023) Vol. 20, Iss. 9, pp. 583-603
Closed Access | Times Cited: 73
Andrew Maltez Thomas, Marine Fidelle, Bertrand Routy, et al.
Nature Reviews Clinical Oncology (2023) Vol. 20, Iss. 9, pp. 583-603
Closed Access | Times Cited: 73
Emerging role of the host microbiome in neuropsychiatric disorders: overview and future directions
Kenji Hashimoto
Molecular Psychiatry (2023) Vol. 28, Iss. 9, pp. 3625-3637
Open Access | Times Cited: 52
Kenji Hashimoto
Molecular Psychiatry (2023) Vol. 28, Iss. 9, pp. 3625-3637
Open Access | Times Cited: 52
Global Meta-analysis of Urine Microbiome: Colonization of Polycyclic Aromatic Hydrocarbon–degrading Bacteria Among Bladder Cancer Patients
Laura Bukavina, Ilaha Isali, Rashida Ginwala, et al.
European Urology Oncology (2023) Vol. 6, Iss. 2, pp. 190-203
Open Access | Times Cited: 22
Laura Bukavina, Ilaha Isali, Rashida Ginwala, et al.
European Urology Oncology (2023) Vol. 6, Iss. 2, pp. 190-203
Open Access | Times Cited: 22
Investigating the causal role of the gut microbiota in esophageal cancer and its subtypes: a two-sample Mendelian randomization study
Jia Li, Xuedi Gao, Xiaoming Sun, et al.
BMC Cancer (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 7
Jia Li, Xuedi Gao, Xiaoming Sun, et al.
BMC Cancer (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 7
Urinary Eubacterium sp. CAG:581 Promotes Non-Muscle Invasive Bladder Cancer (NMIBC) Development through the ECM1/MMP9 Pathway
Yu-Hang Zhang, Wenyu Wang, Hang Zhou, et al.
Cancers (2023) Vol. 15, Iss. 3, pp. 809-809
Open Access | Times Cited: 11
Yu-Hang Zhang, Wenyu Wang, Hang Zhou, et al.
Cancers (2023) Vol. 15, Iss. 3, pp. 809-809
Open Access | Times Cited: 11
Could the tumor-associated microbiota be the new multi-faceted player in the tumor microenvironment?
Anne‐Gaëlle Goubet
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 11
Anne‐Gaëlle Goubet
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 11
Correlation between TCF7 and bladder cancer and feasibility of Erlotinib targeting in bladder cancer: Molecular mechanism and expression of TCF7 recombinant protein
Zeng-mi Mo, Shasha Gai, Xiaopeng Qin, et al.
International Journal of Biological Macromolecules (2025), pp. 140438-140438
Closed Access
Zeng-mi Mo, Shasha Gai, Xiaopeng Qin, et al.
International Journal of Biological Macromolecules (2025), pp. 140438-140438
Closed Access
BCG therapy in bladder cancer and its tumor microenvironment interactions
Jian Ni, Lei Yu, Lijuan Ma, et al.
Clinical Microbiology Reviews (2025)
Closed Access
Jian Ni, Lei Yu, Lijuan Ma, et al.
Clinical Microbiology Reviews (2025)
Closed Access
Microbiome landscapes of the bladder, intestine, and vagina in bladder cancer: a systematic review
Jonathan Surber, Marie Semmler, Dominik Enderlin, et al.
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access
Jonathan Surber, Marie Semmler, Dominik Enderlin, et al.
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access
Optimizing extraction of microbial DNA from urine: Advancing urinary microbiome research in bladder cancer
Chuang-Ming Zheng, Ho Won Kang, Seongmin Moon, et al.
Investigative and Clinical Urology (2025) Vol. 66, Iss. 3, pp. 272-272
Open Access
Chuang-Ming Zheng, Ho Won Kang, Seongmin Moon, et al.
Investigative and Clinical Urology (2025) Vol. 66, Iss. 3, pp. 272-272
Open Access
From mucosal infection to successful cancer immunotherapy
Anne‐Gaëlle Goubet, Mathieu Rouanne, Lisa Derosa, et al.
Nature Reviews Urology (2023) Vol. 20, Iss. 11, pp. 682-700
Closed Access | Times Cited: 10
Anne‐Gaëlle Goubet, Mathieu Rouanne, Lisa Derosa, et al.
Nature Reviews Urology (2023) Vol. 20, Iss. 11, pp. 682-700
Closed Access | Times Cited: 10
Research progress on the microbiota in bladder cancer tumors
Keyuan Lou, Junpeng Chi, Jitao Wu, et al.
Frontiers in Cellular and Infection Microbiology (2024) Vol. 14
Open Access | Times Cited: 3
Keyuan Lou, Junpeng Chi, Jitao Wu, et al.
Frontiers in Cellular and Infection Microbiology (2024) Vol. 14
Open Access | Times Cited: 3
Development of a Molecular-Subtype-Associated Immune Prognostic Signature That Can Be Recognized by MRI Radiomics Features in Bladder Cancer
Shenghua Liu, Haotian Chen, Zongtai Zheng, et al.
Bioengineering (2023) Vol. 10, Iss. 3, pp. 318-318
Open Access | Times Cited: 8
Shenghua Liu, Haotian Chen, Zongtai Zheng, et al.
Bioengineering (2023) Vol. 10, Iss. 3, pp. 318-318
Open Access | Times Cited: 8
The bladder microbiota is not significantly altered by intravesical BCG therapy
Vitor Heidrich, Antonio C. H. Mariotti, Lilian T. Inoue, et al.
Urologic Oncology Seminars and Original Investigations (2023) Vol. 42, Iss. 1, pp. 22.e13-22.e21
Closed Access | Times Cited: 8
Vitor Heidrich, Antonio C. H. Mariotti, Lilian T. Inoue, et al.
Urologic Oncology Seminars and Original Investigations (2023) Vol. 42, Iss. 1, pp. 22.e13-22.e21
Closed Access | Times Cited: 8
The Effect of Sex on the Therapeutic Efficiency of Immune Checkpoint Inhibitors: A Systematic Review and Meta-Analysis Based on Randomized Controlled Trials
Xing‐Yu Zhong, Jian‐Xuan Sun, Na Zeng, et al.
Cancers (2024) Vol. 16, Iss. 2, pp. 382-382
Open Access | Times Cited: 2
Xing‐Yu Zhong, Jian‐Xuan Sun, Na Zeng, et al.
Cancers (2024) Vol. 16, Iss. 2, pp. 382-382
Open Access | Times Cited: 2
Antibiotic therapy impact on intravesical BCG therapy efficacy for high-risk localized bladder cancer treatment
Cécile Aubert, T. Culty, Merzouka Zidane, et al.
Frontiers in Oncology (2024) Vol. 13
Open Access | Times Cited: 2
Cécile Aubert, T. Culty, Merzouka Zidane, et al.
Frontiers in Oncology (2024) Vol. 13
Open Access | Times Cited: 2
Urinary microbiota and metabolic signatures associated with inorganic arsenic-induced early bladder lesions
Xushen Chen, Ying Cheng, Xiaolin Tian, et al.
Ecotoxicology and Environmental Safety (2023) Vol. 259, pp. 115010-115010
Open Access | Times Cited: 5
Xushen Chen, Ying Cheng, Xiaolin Tian, et al.
Ecotoxicology and Environmental Safety (2023) Vol. 259, pp. 115010-115010
Open Access | Times Cited: 5
HPV-Associated Gene Signatures in Bladder Cancer: A Comprehensive Prognostic Model and its Implications in Immunotherapy
Zhicheng Tang, Yuxin Qian, Ni Wang, et al.
International Journal of Medical Sciences (2024) Vol. 22, Iss. 1, pp. 140-157
Open Access | Times Cited: 1
Zhicheng Tang, Yuxin Qian, Ni Wang, et al.
International Journal of Medical Sciences (2024) Vol. 22, Iss. 1, pp. 140-157
Open Access | Times Cited: 1
Microbiome in urologic neoplasms: focusing on tumor immunity
Jun Zou, Baisheng Xu, Hui Gao, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1
Jun Zou, Baisheng Xu, Hui Gao, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1
Microbiome in Bladder Cancer: A Systematic Review
Yong Nam Gwon, Jae-Joon Park, Ki-Soo Lee, et al.
Diagnostics (2022) Vol. 13, Iss. 1, pp. 84-84
Open Access | Times Cited: 5
Yong Nam Gwon, Jae-Joon Park, Ki-Soo Lee, et al.
Diagnostics (2022) Vol. 13, Iss. 1, pp. 84-84
Open Access | Times Cited: 5
Bladder Cancer and Probiotics: What Do We Know So Far?
Pedro Sánchez-Pellicer, Claudia Boix-Rodríguez, Adriana Hernández-Belmonte, et al.
Cancers (2023) Vol. 15, Iss. 23, pp. 5551-5551
Open Access | Times Cited: 2
Pedro Sánchez-Pellicer, Claudia Boix-Rodríguez, Adriana Hernández-Belmonte, et al.
Cancers (2023) Vol. 15, Iss. 23, pp. 5551-5551
Open Access | Times Cited: 2
Urinary Eubacterium sp. CAG:581 promotes non-muscle-invasive bladder cancer (NMIBC) development through ECM1/MMP9 pathway
Yu-hang Zhang, Wenyu Wang, Gang Zhao, et al.
Research Square (Research Square) (2022)
Open Access | Times Cited: 3
Yu-hang Zhang, Wenyu Wang, Gang Zhao, et al.
Research Square (Research Square) (2022)
Open Access | Times Cited: 3
Exploring the bladder tissue microbiome in patients with muscle-invasive bladder cancer using 2bRAD-M sequencing
Zhipeng Yao, He Huang, Si-Han Zhang, et al.
ONCOLOGIE (2024) Vol. 26, Iss. 3, pp. 395-406
Open Access
Zhipeng Yao, He Huang, Si-Han Zhang, et al.
ONCOLOGIE (2024) Vol. 26, Iss. 3, pp. 395-406
Open Access
Urine microbiota and bladder cancer
Igor Yu. Lisitsyn, D. N. Maystrenko, Д. А. Гранов, et al.
Urology reports (St - Petersburg) (2024) Vol. 14, Iss. 3, pp. 315-330
Open Access
Igor Yu. Lisitsyn, D. N. Maystrenko, Д. А. Гранов, et al.
Urology reports (St - Petersburg) (2024) Vol. 14, Iss. 3, pp. 315-330
Open Access
Combining 16s rRNA and LC-QTOF-MS/MS to Explore the Temporal Changes of the Gut Microbiota and Metabolome with Clinical Characteristics of AML Patients
Wanying Liu, Jiajie Yang, Yanxin Chen, et al.
(2024)
Closed Access
Wanying Liu, Jiajie Yang, Yanxin Chen, et al.
(2024)
Closed Access
